info@yilmazerlab.com

Publications

2020

TAHERI H, UNAL, M A, SEVIM M, GURCAN C, EKIM O, CEYLAN A, SYRGIANNIS Z, CHRISTOFORIDIS K C, BOSI S, OZGENÇ O, GÓMEZ M J, TURKTAS ERKEN M, SOYDAL Ç, EROGLU Z, BITIRIM C V, CAGIN U, ARI F, OZEN A, KUÇUK O, DELOGU L G, PRATO M, METIN O, YILMAZER A* (2020) Photocatalytically Active Graphitic Carbon nitride as an Effective and Safe 2D Material for In Vitro and In Vivo Photodynamic Therapy. Small online January 23, 2020.Doi:10.1002/smll.201904619.

2019

GURCAN C, TAHERI H, BIANCO A, DELOGU LG, YILMAZER A*. A closer look at the genotoxicity of graphene based materials. Submitted to Journal of Physics: Materials. Special Issue - Women in Graphene (Invited review). In press.

GAZZI A, FUSCO L, KHAN A, VITALE F*, YILMAZER A*, DELOGU L G*. Photodynamic therapy based on graphene and MXene in cancer theranostics. Frontiers in Bioengineering and Biotechnology.(Invited review). In press.

 

KILIC P, BAY M, YILDIRIM Y, COSKUN O, SEKER S, BAYDIN P, LALEGUL ULKER O, PARMAKSIZ M, CUBUKCUOGLU DENIZ G, YILMAZER A, DALVA K, ELCIN AE, AKCALI KC, ILHAN O, GURMAN G. A CD34+ Cell Enrichment Protocol of Hematopoietic Stem Cells in a Well-Established Quality Management System. Cells Tissues Organs. 2019;207(1):15-20.

 

CASAJUS PELEGAY E, PUZZO F, YILMAZER A*, CAGIN U. Targeting Mitochondrial Defects to Increase Longevity in Animal Models of Neurodegenerative Diseases. Adv Exp Med Biol. 2019;1134:89-110.

TAHERI H, CAGIN U, YILMAZER A*(2019) Reprogramming of Human Melanocytes and Melanoma Cells with Yamanaka Factors. Methods in Molecular Biology. 1916:249-261.

 

DE LÁZARO I, YILMAZER A et al. (2019) Non-viral, Tumor-free Induction of Transient Cell Reprogramming in Mouse Skeletal Muscle to Enhance Tissue Regeneration. Molecular Therapy. S1525-0016(18)30503-3.

2018

YILMAZER A* (2018) Evaluation of cancer stemness in breast cancer and glioblastoma spheroids in vitro. 3Biotech, 8(9):390.

YILMAZER A* (2018) Tendency of K562 chronic myeloid leukemia cells towards cell reprogramming. Turkish Journal of Hematology, 35(4): 260–264.

 

AYDIN T, GURCAN C, TAHERI H, YILMAZER A* (2018) Graphene Based Materials in Neural Tissue Regeneration. Adv Exp Med Biol. 1107:129-142.

2017

YILMAZER A. (2018) Cancer cell lines involving cancer stem cell populations respond to oxidative stress. Biotechnology Reports, 17:24-30.

YILMAZER, A., TAHERI H., CAN A. (2017).  Efficient transduction of melanoma cells with Sendai viralvectors.  Türk Hijyen ve Deneysel Biyoloji Dergisi, 74(2), 113-120., Doi: 10.5505/TurkHijyen.2017.98705

 

YILMAZER, A., TAHERI H. (2017).  Reprogramming human melanocytes and melanoma cells with Yamanaka factors.  Hacettepe Journal of Biology and Chemistry, Doi: 10.15671/HJBC.2017.164


YENER İLÇE B., CAGIN U., YILMAZER A. (2017).  Cellular reprogramming: a new way to understand aging mechanisms.  Wiley Interdisciplinary Reviews: Developmental Biology, Doi: 10.1002/wdev.308.

ÇELİKKAN F., YILMAZER A., GÜNGÖR ORDUERİ N. E., CAN A.. (2017) A Glance at the 2016 Guidelines for Stem Cell Research and Clinical Translation by International Society of Stem Cell Research (ISSCR). J Med Ethics Law Hist-Special Topics 2017;3(2):61-73.

2016

TERALI, K., YILMAZER, A. (2016) New surprises from an old favourite: The emergence of telomerase as a key player in the regulation of cancer stemness.Biochimie, 121:170-8.

2015

YILMAZER, A.,DE LAZARO, I., TAHERİ, H. (2015) Reprogramming cancer cells: A novel approach for cancer therapy or a tool for disease-modeling? Cancer Letters, 369:1-8.

2014

YILMAZER, A., TIAN, B., & KOSTARELOS, K. (2014) Development of dual-activity vectors by co-envelopment of adenovirus and siRNA in artificial lipid bilayers. PLoS One, online December 12, 2014.

DE LAZARO, I., BUSSY, C., YILMAZER, A., SIMONSEN, M., HUMPHREYS, N., KOSTARELOS, K. (2014) Generation of induced pluripotent stem cells from virus-free in vivo cell reprogramming of BALB/c mouse liver. Biomaterials, 35:8312-20.

DE LAZARO, I., YILMAZER, A., KOSTARELOS, K. (2014) Induced pluripotent stem (iPS) cells: a new source for cell-based therapeutics? Journal of Controlled Release, 185:37-44.

 

2013

YILMAZER, A., DE LAZARO, I., BUSSY, C., KOSTARELOS, K. (2013) In vivo reprogramming of adult somatic cells to pluripotency by overexpression of Yamanaka factors. Journal of Visualized Experiments, online December 17, 2013.

YILMAZER, A., DE LAZARO, I., BUSSY, C., KOSTARELOS, K. (2013) In vivo cell reprogramming towards pluripotency by non-viral overexpression of defined factors. PLoS One, online January 23, 2013.

 

2012

YILMAZER, A., AL-JAMAL, W., VAN DEN BOSSCHE, J. & KOSTARELOS, K. (2012) The fate of artificially enveloped adenovirus in vivo: liver de-targeting with reduced hepatotoxicity. Biomaterials, 34, 1354-63.

 

2011

VAN DEN BOSSCHE, J. AL-JAMAL, W., YILMAZER, A., TIAN, B., BIZZARRI, E. & KOSTARELOS, K. (2011) Intracellular trafficking and gene expression of pH-sensitive, artificially enveloped adenoviruses in vitro and in vivo. Biomaterials, 32, 3085-3093

 

2011

AL-JAMAL, K. T., TOMA, F. M., YILMAZER, A., E., ALI-BOUCETTA, H., NUNES, A., HERRERO, M.-A., TIAN, B., EDDAOUI, A., AL-JAMAL, W. T., BIANCO, A., PRATO, M. & KOSTARELOS, K. (2010) Enhanced cellular internalization and gene silencing with a series of cationic dendron-multiwalled carbon nanotube:siRNA complexes. The FASEB Journal, 24, 4354-4365.

AL-JAMAL, K. T., AL-JAMAL, W. T., AKERMAN, S., PODESTA, J. E., YILMAZER, A., E., TURTON, J. A., BIANCO, A., VARGESSON, N., KANTHOU, C., FLORENCE, A. T., TOZER, G. M. & KOSTARELOS, K. (2010) Systemic antiangiogenic activity of cationic poly-L-lysine dendrimer delays tumor growth. Proceedings of the National Academy of Sciences, 107, 3966-3971.

 

2008

ZHU, X., MULCAHY, L., MOHAMMED, R., LEE, A., FRANKS, H., KILPATRICK, L., YILMAZER, A., PAISH, E. C., ELLIS, I., PATEL, P. & JACKSON, A. (2008) IL-17 expression by breast-cancer-associated macrophages: IL-17 promotes invasiveness of breast cancer cell lines. Breast Cancer Research, 10, R95.

 

Books


2017
 

In Vivo Reprogramming in Regenerative Medicine, Chapter 7: Challenges and future perspectives for in vivo reprogramming technology (2017)., TAHERI HADISEH, GURCAN CANSU, YILMAZER AKTUNA AÇELYA,  Springer, Editor:Açelya Yılmazer Aktuna, Edition:1.
 

In Vivo Reprogramming in Regenerative Medicine, Chapter 1: Introduction to in vivo cell reprogramming technology (2017)., GURCAN CANSU, TAHERI HADISEH, YILMAZER AKTUNA AÇELYA,  Springer, Editor:Açelya Yılmazer Aktuna, Edition:1.


2016
 

Telomere   A Complex End of a Chromosome, Bölüm adı:(On the Far Side of Telomeres: The Many Roles of Telomerase in the Acquisition and Retention of Cancer Stemness) (2016)., TERALI KEREM, YILMAZER AKTUNA AÇELYA,  Intech, Editor:Larramendy, Marcelo L. , Edition:1.
 

Encyclopedia of Cancer, Bölüm adı:(iPS Cells) (2016)., YILMAZER AKTUNA AÇELYA,  Springer, Editor:Manfred Schwab, Edition:4, ISBN:978-3-642-27841-9.